Meeting
2018 Gastrointestinal Cancers Symposium
Assessment and prognostic impact of a new classification using HER2 and HER3 status in resected gastric cancer in a european cohort.
Authors
Nieves Martinez Lago
Universitary Hospital of A Coruña, A Coruña, Spain
Nieves Martinez Lago , Ihab Abdulkader , Dora Insua Santamaria , Patricia Viaño Nuñez , Juan Jose Carrera , Jose Ramón Antunez Lopez , Maria Elena Padin Iruegas , Rafael López López
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Translational Research
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 65)
DOI
10.1200/JCO.2018.36.4_suppl.65
Abstract #
65
Poster Bd #
F17
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Frequency of overexpression of HER3 and prognostic consequences in European patients with early gastric cancer.
First Author: Nieves Martinez Lago
Poster
2015 Gastrointestinal Cancers Symposium
Discordances in HER2 status between primary gastric cancer and corresponding metastatic sites.
First Author: Ozge Gumusay
Poster
2024 ASCO Gastrointestinal Cancers Symposium
The expanded indications of HER2-targeted therapies by monitoring of circulating tumor cells.
First Author: Yasuaki Kimura
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Clinicopathological features of HER2-low expressed advanced gastric cancers.
First Author: Izuma Nakayama